tiprankstipranks
Advertisement

AVIE - ETF AI Analysis

Compare

Top Page

AVIE

Avantis Inflation Focused Equity ETF (AVIE)

Rating:71Outperform
Price Target:
AVIE, the Avantis Inflation Focused Equity ETF, has a solid overall rating, largely supported by high-quality blue-chip holdings like Johnson & Johnson and PepsiCo, which benefit from strong financial performance, positive earnings calls, and clear strategic initiatives. Other major positions such as Exxon Mobil, Eli Lilly, and UnitedHealth also add strength through robust fundamentals and generally positive outlooks, though some face challenges like leverage, cash flow pressures, or segment-specific risks. On the weaker side, Berkshire Hathaway’s bearish technical momentum and Philip Morris’s high leverage and bearish outlook slightly weigh on the fund, and investors should note the concentration in large, established companies that can still face revenue growth and valuation pressures.
Positive Factors
Solid Recent Performance
The ETF has shown strong gains so far this year and in recent months, indicating positive momentum.
Inflation-Resilient Sector Mix
Heavy exposure to energy, health care, and consumer defensive companies can help the fund hold up better when inflation is elevated.
Reasonable Expense Ratio
The fund’s fee is moderate for an actively managed, specialized equity ETF, allowing investors to keep more of their returns.
Negative Factors
Very Small Fund Size
With relatively low assets under management, the ETF may face higher trading spreads and a greater risk of closure than larger funds.
High U.S. Concentration
Almost all of the portfolio is invested in U.S. stocks, offering little geographic diversification.
Mixed Performance Among Top Holdings
Some of the largest positions, including major financial and health care names, have recently lagged, which can drag on overall returns.

AVIE vs. SPDR S&P 500 ETF (SPY)

AVIE Summary

The Avantis Inflation Focused Equity ETF (AVIE) is a U.S.-focused stock fund that aims to do well when prices in the economy are rising. It doesn’t track a set index, but instead picks companies that may handle inflation better, especially in energy, health care, and consumer staples. Well-known holdings include Berkshire Hathaway, Exxon Mobil, Procter & Gamble, and Coca-Cola. Someone might invest in AVIE to stay in the stock market while trying to protect their money’s buying power and get broad diversification. A key risk is that it can still lose value and move up and down with the overall stock market.
How much will it cost me?The Avantis Inflation Focused Equity ETF (AVIE) has an expense ratio of 0.25%, which means you’ll pay $2.50 per year for every $1,000 invested. This cost is lower than average for actively managed ETFs because it focuses on inflation-conscious equity investments while maintaining broad market exposure.
What would affect this ETF?The Avantis Inflation Focused Equity ETF (AVIE) could benefit from rising inflation, as its focus on companies with strong pricing power and fundamentals may help it perform well in such environments. Positive trends in sectors like Health Care and Energy, which make up a significant portion of its holdings, could also drive growth. However, economic slowdowns or regulatory changes affecting key sectors like Energy or Financials, as well as declining inflation concerns, could negatively impact its performance.

AVIE Top 10 Holdings

AVIE is leaning hard into classic inflation fighters, with energy giants like Exxon and Chevron doing much of the heavy lifting despite some recent choppiness, while their longer-term uptrend keeps the fund’s inflation story intact. Health care is another anchor: UnitedHealth is rising and Johnson & Johnson looks steady, helping offset a lagging Eli Lilly, which has lost some momentum. On the defensive side, staples such as PepsiCo are quietly climbing, while Procter & Gamble and Philip Morris feel a bit sluggish. With a U.S.-only lineup and no single mega-cap dominating, the fund spreads its bets across resilient, cash-generating names rather than chasing high-flying tech.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Berkshire Hathaway B5.26%$458.06K$1.01T-10.95%
66
Neutral
Exxon Mobil4.97%$432.73K$618.95B36.42%
74
Outperform
Procter & Gamble3.84%$334.44K$344.37B-8.31%
69
Neutral
Chevron2.94%$256.15K$369.57B31.89%
71
Outperform
Eli Lilly & Co2.88%$251.04K$835.18B-1.03%
72
Outperform
UnitedHealth2.57%$223.60K$322.15B-15.55%
72
Outperform
Johnson & Johnson2.25%$195.88K$547.64B45.05%
78
Outperform
Philip Morris2.23%$194.08K$255.91B-4.89%
61
Neutral
PepsiCo2.14%$186.84K$212.45B15.21%
78
Outperform
Coca-Cola2.08%$181.61K$329.83B5.08%
75
Outperform

AVIE Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
72.67
Positive
100DMA
70.40
Positive
200DMA
66.23
Positive
Market Momentum
MACD
0.34
Negative
RSI
63.76
Neutral
STOCH
94.52
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AVIE, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 72.74, equal to the 50-day MA of 72.67, and equal to the 200-day MA of 66.23, indicating a bullish trend. The MACD of 0.34 indicates Negative momentum. The RSI at 63.76 is Neutral, neither overbought nor oversold. The STOCH value of 94.52 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AVIE.

AVIE Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$8.91M0.25%
71
Outperform
$95.88M0.89%
69
Neutral
$93.17M0.85%
71
Outperform
$93.06M0.75%
68
Neutral
$82.86M0.65%
62
Neutral
$80.95M0.52%
71
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AVIE
Avantis Inflation Focused Equity ETF
73.90
14.44
24.29%
BAMD
Brookstone Dividend Stock ETF
STNC
Stance Equity ESG Large Cap Core ETF
SOVF
Sovereign's Capital Flourish Fund
VAMO
Cambria Value & Momentum ETF
RFDA
RiverFront Dynamic US Dividend Advantage ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement